Evidence map›Paper›PMID 25664024›Full record

ArticleInternational journal of clinical and experimental medicine2014

Analysis of prognostic factors and comparison of prognostic index scores in patients with brain metastases after whole-brain radiotherapy.

Judong Luo, Hong Zhu, Yiting Tang, Honglin Wang, Xifa Zhou, Xujing Lu, Shuyu Zhang, Yunhai Li

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Judong LuoDepartment of Radiotherapy, Changzhou Tumor Hospital, Soochow University Changzhou 213001, China.
Hong ZhuDepartment of Radiation Oncology, Minhang Branch of Cancer Hospital of Fudan University Shanghai 200240, China.
Yiting TangDepartment of Radiotherapy, Changzhou Tumor Hospital, Soochow University Changzhou 213001, China.
Honglin WangDepartment of Radiation Oncology, Minhang Branch of Cancer Hospital of Fudan University Shanghai 200240, China.
Xifa ZhouDepartment of Radiotherapy, Changzhou Tumor Hospital, Soochow University Changzhou 213001, China.
Xujing LuDepartment of Radiotherapy, Changzhou Tumor Hospital, Soochow University Changzhou 213001, China.
Shuyu ZhangSchool of Radiation Medicine and Protection and Jiangsu Provincial Key Laboratory of Radiation Medicine and Protection, Medical College of Soochow University Suzhou 215123, China ; Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions and School for Radiological and Interdisciplinary Sciences (RAD-X), Soochow University Suzhou 215123, China.
Yunhai LiDepartment of Radiation Oncology, Minhang Branch of Cancer Hospital of Fudan University Shanghai 200240, China.
Fudan University Shanghai Cancer Center · CNSoochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeBrain metastases (BMs) are typically associated with poor patient prognosis. Radiation therapy remains the primary treatment for BMs, and patient's prognosis is affected by many factors. The aim of this study was to identify prognostic factors and to compare prognostic index scores in patients with BMs who received whole-brain radiotherapy (WBRT).

methodsA retrospective prognostic study was conducted in 125 patients with BMs who underwent WBRT between Jan 2008 and Jul 2011. The significance of prognostic variables with regard to survival was determined using univariate and multivariate analyses. A prognostic index (PI) was established based on Cox regression analysis and subgrouping values. The recursive partitioning analysis classes (RPA), basic score for brain metastases (BS-BM), Graded Prognostic Assessment index (GPA), and PI were assessed with regard to prognosis.

resultsThe median survival time was 213 days (7.1 months). In the univariate analysis of the test group, survival was significantly associated with Karnofsky performance status (KPS) score, the number of BMs, the presence of extracranial metastases, primary tumor status and the number of involved extracranial organs. The multivariate analysis showed that the KPS score (P = 0.002, Wald = 9.700), presence of extracranial metastases (P = 0.018, Wald = 5.604) and primary tumor status (P = 0.001, Wald = 10.212) were significantly correlated with overall survival. RPA, BS-BM and GPA were all closely related to prognosis, as determined using a log-rank test. In predicting the 3- and 6-month survival for patients, the PI was superior to the other three modes.

conclusionsThe three indexes, RPA, BS-BM and GPA, are valid prognostic index models; however, the PI model was the most powerful.

Indexed as

brain metastasesNeoplasmsprognosisprognostic index scoreswhole-brain radiotherapy

Identifiers

PMID25664024
PMCPMC4307471
OpenAlexW2395438194

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.